Osiris Receives $5 Million Milestone Payment
The adult stem cell company Osiris Therapeutics reaches a production milestone in its agreement with NuVasive.
January 8, 2009
The adult stem cell company Osiris Therapeutics reaches a production milestone in its agreement with NuVasive.
After reporting strong fourth-quarter growth, Genzyme announces an optimistic economic forecast.
The umbilical cord blood stem cell preservation company, Cord Blood America, announces a new campaign to engage the attention and interest of clients, investors and the general public through the new platform of social networking technology.
The California based biotechnology company ISCO receives the first $1 million tranche of private equity funding.
Anthrogenesis Corporation, a division of Celgene, is awarded yet another U.S. patent for inventions related to methods of deriving adult stem cells from human placentas.
A U.S. doctor has been invited to visit China as part of a fact-finding mission on the current state of stem cell therapies that are only available outside of the United States.
Toll Free:
1-800-980-STEM (7836)
Outside or Inside US Call:
1-954-358-3382
Toll Free Fax (US Only):
1-866-755-3951
From Outside US Fax:
1-775-887-1194
Copyright 2025, Stem Cell Insitute Panama. All rights reserved.